Technical

Address nitrosamine risk mitigation
with confidence

Global regulatory bodies have introduced a legal obligation for drug manufacturers to implement mitigation strategies that aim to minimize the risk of nitrosamine formation in drug products. The addition of antioxidants to drug formulations is a safe and viable, FDA-recommended mitigation strategy for inhibition of nitrosamine formation in drug products. Prevention of formation of potentially carcinogenic impurities is possible with commonly used ascorbic acid and alpha-tocopherol. 

 

Learn more

Technical

Our commitment to innovation is unparalleled. Partnering with DSM ensures access to a global network of application labs and expert knowledge, for all your new product development needs. 

We have a strong track record of joint innovation and collaboration with key opinion leaders, providing crucial API support across specific applications. We can tailor our approach to match your requirements, developing high-quality, sustainable products that take you further in the pharmaceutical industry.  

Contact us to explore how our unique technical capabilities can help you get to market faster.

Latest Articles

APIs for Pharma Applications

Explore our broad portfolio of API Vitamins, Lipids and Novel APIs

Latest Scientific Research

Our whitepapers summarize the latest research developments, covering key topics in the industry

Quick Links

Webshop

Request samples, place orders and view product documentation

Catalogue

Download the latest copy of our Solutions Catalogue

Contact Us

We’re more than a partner. We’re a competitive edge.

Whitepapers

The latest in vitamin and lipid research and industry developments

Webinars

Academic studies and the latest science in educational modules

Videos

Videos exploring the growing role of vitamin APIs and lipid API intermediates

Address nitrosamine risk mitigation with confidence

Global regulatory bodies have introduced a legal obligation for drug manufacturers to implement mitigation strategies that aim to minimize the risk of nitrosamine formation in drug products. The addition of antioxidants to drug formulations is a safe and viable, FDA-recommended mitigation strategy for inhibition of nitrosamine formation in drug products. Prevention of formation of potentially carcinogenic impurities is possible with commonly used ascorbic acid and alpha-tocopherol. 

Learn more